for the Period Ended 31 January 2024
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
(
|
(
|
Gross profit(or loss): |
|
|
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
|
( |
Profit(or loss) before tax: |
|
( |
Profit(or loss) for the financial year: |
|
( |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Called up share capital not paid: |
|
|
|
Fixed assets | |||
Tangible assets: | 3 |
|
|
Total fixed assets: |
|
|
|
Creditors: amounts falling due within one year: | 4 |
(
|
(
|
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
|
( |
|
Total net assets (liabilities): |
|
( |
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Profit and loss account: |
|
( |
|
Total Shareholders' funds: |
|
( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 January 2024
Basis of measurement and preparation
for the Period Ended 31 January 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 January 2024
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 1 February 2023 |
|
|
||||
Additions | ||||||
Disposals | ||||||
Revaluations | ||||||
Transfers | ||||||
At 31 January 2024 |
|
|
||||
Depreciation | ||||||
At 1 February 2023 | ||||||
Charge for year | ||||||
On disposals | ||||||
Other adjustments | ||||||
At 31 January 2024 | ||||||
Net book value | ||||||
At 31 January 2024 |
|
|
||||
At 31 January 2023 |
|
|
for the Period Ended 31 January 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Bank loans and overdrafts |
|
|
Other creditors |
|
|
Total |
|
|
The company provides holistic therapy and acupuncture sessions to people of all ages suffering from anxiety and stress.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
28 October 2024
And signed on behalf of the board by:
Name: Razvan Syyed
Status: Director